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ABA allergic bronchopulmonary as 
band band neutrophil 
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HPF high power field (970x) 
hr hour(s) 
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L 1iter(s) 
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Traditionally, allergic rhinitis and asthma are considered Type 
I (anaphylactic) reactions (1). The reaction is mediated by histamine, 
released from the mast cell (or basophil) by the binding of its attached 
irmumoglobul in E (IgE) to the antigen. Histamine, and possibly other 
vasoactive amines, act pharmacologically producing the clinical symptoms 
of rhinitis, bronchospasm and/or urticaria. This occurs within minutes, 
and resolves within 1-2 hours. 
However, there is substantial evidence that late asthmatic (2-24) 
and late nasal (24-28) responses occur, beginning as early as 3 hours 
(9) and lasting up to one week (2). 
It is quite important to differentiate between early and late 
allergic responses. Nocturnal symptoms may be due to continued 
provocation (i.e. house dust), or theoretically may be a late response 
to provocation occurring 12 hours earlier. 
In addition to determining the offending stimulus, it is important 
to select the proper therapeutic agent. In allergic rhinitis, anti¬ 
histamines have traditionally been the treatment of choice (1). However, 
these drugs alone are often insufficient. Beclomethasone and other 
adrenal steriods, applied topically, are quite effective in the treatment 
of hayfever (28,30-32). Recent evidence (28) suggests that the clinical 
effect of topical steroids is based on their ability to block late 
nasal responses. 
There is similar evidence demonstrating the effectiveness of 




cromoglycate (DSCG) (Intal), has been found effective in both asthma 
(5,8,9,12,20,34) and allergic rhinitis (35-37). 
There are several thoughts as to the etiology of these late 
responses, which occur in the nasal mucosa, bronchi, and skin (14,24,26, 
38-49). Some favor the involvement of immune complexes or an Arthus 
reaction -- Type III hypersensitivity (7,8,10,12,24,26,28). Others have 
commented that the late ("delayed") response may be cel 1-mediated 
(Type IV) (27,28,40). 
Several investigators have examined the role of basophils in late 
responses (38,41,45). This research was motivated by the model of 
"cutaneous basophil hypersensitivity" (CBH), a late cutaneous response 
in guinea pigs (50-52). CBH has a maximal skin response at 24 hours 
(50,51), and biopsy of the lesion demonstrates a marked accumulation of 
basophils in the dermis (52). 
Basophils have recently been noted in the nasal secretions of 
subjects with allergic rhinitis (53). Other studies have correlated 
peripheral basophil counts with allergic symptoms (54-57). 
Peripheral eosinophilia is frequently associated with allergic 
disease (57-59). The presence of eosinophilia in nasal secretions is 
virtually pathognomonic for allergic rhinitis (1,59-62). Eosinophils 
have also been found in biopsies of late responses (39,41,45). 
The objective of this thesis was to reproducibly elicit late 
allergic responses, and to investigate further the possible role of 
basophils and eosinophils in non-immediate hypersensitivity. Late nasal 
responses were chosen in particular, because bronchial provocation 
testing may require hospitalization in the event of a severe immediate or 
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late response. In addition, nasal secretions can be easily obtained 
and studied. 

LATE ALLERGIC RESPONSES 
The Late Cutaneous Response (LCR) 
In 1934, Jones and Mote (63), in the process of investigating 
foreign protein sensitization in humans, noted the occurrence of an 
immediate wheal and flare, followed at 24 hours by a tuberculin type 
reaction. 
In recent years, the LCR has been more thoroughly studied, and is 
probably better understood than late nasal or bronchial responses. 
Solley et al. (45) describe a pruritic wheal and flare response after 
antigenic challenge (to pollens and molds), reaching a peak at 15-30 
minutes. Over the next hour, the wheal becomes less distinct, merging 
into the flare. At 90 minutes, the lesion is diffusely edematous and 
erythematous, but asymptomatic. The lesion remains as such until 4-5 
hours post-provocation, when mild pruritis reoccurs. The late response 
peaks at 6-12 hours, consisting of erythema, warmth, edema, pruritis, 
and/or tenderness. It is much greater in area than the initial reaction, 
and often causes greater subjective discomfort. The lesion persists for 
24-48 hour macroscopically. 
The LCR occurs in a minority of subjects at the usual low intra- 
cutaneous doses (26,39), but can be elicited in virtually all subjects 
at high enough doses (14). 
Umemoto et al. (46) describe a threshold of an 8 mm immediate 
response for the occurrence of a late response. However, other 
investigators (39) have described a late response in nonatopics, 
occurring independently of the wheal and flare. In studies (42) with 




proteinase activity was not necessary for the LCR. Other studies (48) 
have demonstrated a local relative refractory period of 2-3 weeks, 
during which time the LCR may occur, but is considerably reduced. This 
effect is nonspecific, and the mediation unknown. 
Much effort has been expended studying the relationship of the wheal 
and/or flare to the LCR. Brostoff and Roitt (40) ablated the wheal and 
flare with intradermal chlorpheniramine, but noted the development of a 
delayed response, maximal at 36 hours. This result could not be confirmed 
by others (64,65). Green et al. (39) noted over 20% of their LCR's 
occurred in subjects with a negative immediate response. Umemoto et al. 
(46) ablated only the flare response (mediated by local sensory nerves), 
and found no change in the LCR. 
Of particular interest is the observation that prednisone inhibits 
the late response (24,44), but has no effect on the wheal and flare (66). 
Many investigators (24,26,38,39,41,45,49) have biopsied the LCR, 
studying the role of leukocytes, immunoglobulins, complement, and fibrin 
(see Table I). The infiltrate varies from "scanty" (24) to "intense" 
(39), and consists of a mixed variety of cells -- mainly neutrophils, 
lymphocytes and eosinophils. Only one study (24) has demonstrated IgG, 
and two studies have demonstrated bound complement (24,26). 
Recently, De Shazo et al. (49) demonstrated fibrin to be the 
distinguishing feature between those sites with a positive LCR and a 
positive wheal-negative LCR control; as the cellular infiltrate was 
qualitatively the same in both groups (38). 
The varying results above have suggested multiple etiologies of the 
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participants. The function of the eosinophil is especially intriguing. 
Eosinophils have also been found in biopsies of the wheal and flare, as 
early as 15 minutes after antigen challenge (67). It has been suggested 
(43) that eosinophils are attracted to the site of the LCR, and act 
similarly to neutrophils in the Arthus reaction. 
Other investigators (24,26) feel that the LCR is an Arthus reaction, 
based on the finding of IgG and/or bound complement in skin biopsies (see 
above). It was considered that previous hyposensitization may have 
resulted in the formation of precipitins capable of producing immune 
complexes, but no correlation between such therapy and the LCR was found 
(26). 
The LCR has also been thought to be a Type IV reaction. It is 
capable of transfer by peripheral leukocytes (68), and can occur at 36-72 
hours (40). Also, positive leukocyte stimulation (27,40) and macrophage 
migration-inhibition tests (40) have been found in some patients with 
late responses. 
More recent research focuses on the role of mediators and immuno¬ 
globulins, specifically IgE. The LCR can be transferred with serum 
(Prausnitz-Kustner) (43,45); but not with heated serum, or serum following 
treatment with anti-IgE immunoabsorbent (45). A dual response (wheal and 
flare followed by LCR) can be elicited by antiserum to human myeloma 
IgE (43). This response seems identical to the antigen-induced response, 
and is also inhibited by prednisone (44). Excessive quantities of IgE 
myeloma protein can inhibit both the immediate and LCR (45). 
But the mediation of the LCR is still quite obscure. Histamine alone 
cannot mediate the LCR, which occurs on the presence of antihistamines (40); 
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and intradermal injection of histamine produced a significant wheal and 
flare, but no LCR (45,69). Similar injections with bradykinin or a 
combination of bradykinin and histamine could not produce the LCR (45,69). 
However, the injection of Compound 48/80, causing degranulation of 
mast cells, is effective in producing a response similar to the LCR (45). 
Even more interesting is the finding that intradermal injection of 
kallikrein causes a wheal and flare, followed by a superficial, erythem¬ 
atous, tender nonpruritic dermal infiltration peaking at 5-24 hours, and 
lasting for up to 48 hours (69). This response was even greater in 
patients with hereditary angioneurotic edema (70). 
One can speculate on a possible explanation linking the appearance 
of complement (24,26) and fibrin deposits (49), with the effects of 
kallikrein. The activation of Hageman factor (XII) can initiate the 
coagulation system (leading to fibrin production), fibrinolytic system 
(leading to plasmin, and activation of the complement system), and 
kinin system (leading to kallikrein production) (1). Quite possibly, 
all of these systems may be involved in the LCR, but not simultaneously; 
thus the great discrepancy in data described above. It would be 
interesting to try and block the LCR with kallikrein inhibitor. 
Late Responses in the Upper Respiratory Tract 
Before discussing the late nasal response (LNR), it is necessary to 
introduce two important technical methods for eliciting and assessing 
the existence of such a response. More difficult than intradermal 
injections, nasal provocation testing (NPT) requires a well-defined 
methodology to properly produce an immediate and/or LNR. The technique of 
rhinomanometry (RM) is often used to define the existence of a nasal response. 
. 
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Rhinomanometry. The technique of RM has evolved from crude clinical 
methods, to sophisticated electronic gadgetry. The first methods were 
qualitative, comparing one nostril to the other, by determining the 
condensation of moisture on a mirror (71). Similarly, the pitch of the 
tone given off during expiration through one nostril (72), has provided 
the otolaryngologist with a qualitative assessment of nasal obstruction. 
Another noninvasive method was devised by Taylor et al. (73). Using 
a Wright flow meter, they assessed the amount of nasal obstruction by 
determining the ratio of the nasal peak flow to the oral peak flow. 
Their results correlated closely to those of standard RM. 
Rhinomanometric techniques can be divided into two broad categories, 
anterior and posterior. Anterior techniques are generally less invasive, 
involving the use of exterior, or at most nasal intubation. The pressure 
difference between the nasopharynx and ambient pressure is recorded in 
one nostril, while flow is recorded in the other (74). As there is no 
flow in one side, its external pressure is equal to that of the naso¬ 
pharynx. (Pressure = flow X resistance. If the flow is zero, then the 
pressure change through that region is also zero.) 
The posterior methods require intubation of the posterior oropharynx 
or nasopharynx, to determine the difference between ambient pressure and 
the mesopharynx (74). This method can be more difficult, as subjects 
must relax the soft palate to produce undistorted recording (75). 
Both types of methods have been found satisfactory (74,76). Anterior 
methods are more sensitive (76), but probably less specific (74). 
However, they are much more tolerable for the subject. Anterior methods 
measure each nostril individually, but calculation of the total resistance 
is not as accurate as direct measurement by posterior methods. 
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All rhinomanometric methods are based on the assumption of a linear 
relationship between pressure and flow, or constant resistance. This has 
been demonstrated to be valid at low flow rates (less than 12 L/min), but 
nonlinear at progressively higher rates (29,77,78). 
Nasal provocation testing. Often the allergic patient describes a 
clinical history that cannot be confirmed by intradermal testing, or 
vice versa (79). This often results in confusion about whether or not to 
treat the allergen in question. A more accurate method is directly 
testing the end organ, by means of NPT. 
The idea is not new, first utilized by Blackley in 1873 (80). Dry 
pollen was used in the early studies. The usual technique was spraying, 
but Blumstein (79) devised the unique method of allowing the subject to 
inhale the pollen from the blunt end of a toothpick. If the patient's 
usual rhinitic symptoms occurred (sneezing, rhinorrhea, and/or obstruction), 
the test was considered positive. He found "the dry pollen nasal test" 
specific in all but 7% of the cases. It corroborated the histories and 
skin tests in 86% of the cases. 
However, the test required greater reproducibility. Connell (81) 
devised the first quantitative method for NPT. He was able to deliver a 
fixed number of pollen grains per minute, to reproduce environmental 
conditions of seasonal rhinitis. 
More recent studies have utilized sophisticated equipment, including 
delivery of pollen via a compressor-powered atomizer (82). The air flow 
was measured by a rotameter, and duration of flow by a timing unit. This 
operated a solenoid, which controlled the compressor. 
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The role of NPT today is controversial. There is a significant lack 
of conformity between skin and nasal testing (60,83). One study (83) 
found an overall agreement of 77%. It also seems that some allergens 
yield better correlations than others (grass pollen, house dust mite) (60). 
The emergence of the radioallergosorbent test (RAST) (84), which 
measures the quantity of specific IgE, is one factor in the decreased use 
of NPT. Eriksson (85) found a 100% agreement with the MPT, utilizing a 
combination of the case history, skin testing, and RAST. The correlation 
between RAST and NPT was only 77%, and the correlation between NPT and a 
combination of the case history and skin testing was 90%. Another study 
(86) found no clear positive quantitative correlation between skin testing 
and NPT; suggesting that local IgE production is of primary importance. 
In light of the above, NPT still seems to be a reasonably safe, quick, 
and inexpensive method of determining the significance of clinical allergy 
to a specific antigen. 
The late nasal response. In 1934, Simon and Rackemann (87) noted 
the symptoms of nasal obstruction, thin serous discharge and sneezing, 
following the instillation of guinea pig serum via nasal packing (in 
sensitized individuals). Occasionally, this response occurred at 10-15 
minutes (after provocation), but usually it began within from 6-24 hours, 
and lasted from 2-6 days. 
Slavin et al. (25) repeated the above study with similar results. 
Also, using nasal packs saturated with ragweed pollen extract, there was 
no immediate response (in nonatopics with induced sensitivity). But 
rhinorrhea and mild congestion occurred at 6 hours, increasing by 24 hours, 
and disappearing by 48 hours. In contrast, nasal insufflation of ragweed 
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(in naturally sensitive subjects) produced immediate symptoms, which 
disappeared within an hour, without recurrence. 
Pelikan (28) describes three different types of nasal response: 
immediate, late (6-10 hours), and delayed (after 24 hours). The immediate 
response is characterized by severe rhinorrhea and sneezing, with 
moderate obstruction. The late response consists of severe obstruction, 
with only slight rhinorrhea and sneezing. The delayed response is 
similar to the late, except for even less sneezing and rhinorrhea. 
There is some controversy over the frequency of occurrence of the 
LNR. Various studies have recorded from 0% to 60% late responses, in 
subjects known to be sensitive to the allergen (see Table 11 )(24,26,28, 
29,30). 
The correlation between the LCR and the LNR is high in those studies 
(24,26) reporting a high frequency of LNR. This has led these investi¬ 
gators to postulate a common mechanism. 
It is also interesting that previous tonsillectomy is associated 
with an increased frequency of LNR (26). This may be secondary to the 
tonsillectomy itself, or to an increased incidence of tonsillectomy in 
children with severe, prolonged nasal allergy. 
The etiology of the LNR is probably more confusing than that of the 
LCR. Most investigators believe the two responses are intimately related. 
Several groups (24,26,28) have implicated the Arthus reaction (Type III 
hypersensitivity), but the evidence is totally circumstantial; based on 
findings in skin biopsies in these individuals (see previous section). 
Other investigators (27,28) claim the LNR to be a delayed-type 
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A "priming effect" was described by Connell (88) in an elaborate 
series of experiments in 1968, prior to most of the work on late allergic 
responses. He noted that one-hour nasal challenges (using his method 
described in previous section) daily, for four days, decreased the nasal 
threshold to provocation more than five-fold. This effect was readily 
reversed after several days without challenge. Only the nostril challenged 
was "primed", and the effect was nonspecific -- priming with one antigen 
facilitated challenge with another (89). If challenged for four consecutive 
weeks, more than five weeks were required until the subject's threshold 
returned to baseline. 
Nasal biopsies of "primed" subjects revealed a marked histiocytosis, 
a dense infiltrate of foamy cells, and many eosinophils (90). In addition, 
there was destruction of the basement membrane. 
Because of the nonspecificity of priming, household allergens of 
little importance during the majority of the year will cause clinical 
(often nocturnal) symptoms in the patient during a pollen season (91). 
Repeated provocation, leading to mucosal change and a decreased threshold 
(followed by a cascade of more challenge and more damage), could be a 
cause of late nasal (and bronchial) responses to inhalant allergens. 
However, it is difficult to explain the occurrence of late responses 
following a single provocation, and the priming effect does not apply to 
cutaneous responses. 
Taylor and Shivalkar (86) report a local desensitization effect, 
contrary to Connell's results. They demonstrated an increase in threshold 
dose following repetitive challenge. 
Despite the low incidence of the LNR in some studies, it may be a 
very important clinical phenomenon. One patient has been described with 
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a typical syndrome of seasonal rhinitis, but negative immediate responses 
to skin and nasal challenge with pollens (27). However, he did have 
late responses at 24-48 hours following provocation with tree pollens. 
This patient had no specific IgE or IgG, but his lymphocytes could be 
stimulated specifically in vitro by pollen extract. The lack of specific 
IgE is consistent with previous studies (85) on the correlation between 
RAST and NPT. The significance of the positive lymphocyte stimulation 
test is unclear. 
Hay fever sufferers are much less symptomatic at the beginning of a 
pollen season, than at the end (91). In fact, the pollen count may be near 
zero at the end of the season, and the patient will be more symptomatic 
than at high pollen counts at the beginning of the season (26). This 
clinical finding is consistent with Connell's priming effect (91), 
although others attribute it to a prolonged Type III reaction (26). 
Topical corticosteroids are quite effective in allergic rhinitis 
(31,32), despite their lack of effectiveness on the immediate nasal 
response (92,93). One study (30) demonstrated an almost total ablatement 
of the LNR with beclomethasone. Also noted was a significant reduction in 
the immediate nasal response with topical steroids, not previously 
demonstrated. 
DSCG also seems to be effective in protecting against nasal provocation 
(35,37), although there is conflicting evidence (94) on its usefulness in 
allergic rhinitis. DSCG is quite effective in blocking the late bronchial 
response (5,8,9,12,20), and is often used clinically for asthma. 
Histology of nasal allergy. The examination of nasal secretions is 
an important step in the diagnosis of allergic rhinitis (1). The 
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predominant cells in nasal secretions are epithelial in origin, although 
leukocytes are frequent in nasal specimens collected by blowing ("blown") 
(53). 
Many clinicians and investigators have examined nasal smears for 
eosinophils, using both swabbed and blown specimens. 50-90?4 of individuals 
with allergic rhinitis have significant nasal eosinophilia (59,61,62), 
compared to only 5% of control subjects (59). Nasal eosinophilia tends to 
decrease following hyposensitization (62). Eosinophils can sometimes be 
seen in nasal smears after NPT, usually associated with a positive 
clinical response (60). 
Mast cells have also been found in nasal secretions. This was first 
noted in 1959 by Bryan and Bryan (95,96). Mast cells can be found in 
80-98% of nasal smears from adults with symptomatic allergic rhinitis 
(53,61). The mast cells are less frequent in children (61), and are not 
found in blown specimens (53). They are associated with clinical symptoms 
of allergy, and disappear following treatment with nasal dexamethasone 
(53). 
Basophils have also been noted in blown nasal secretions, but are 
absent in scraped specimens (53). Like mast cells, they are only present 
in symptomatic allergic subjects. 
In biopsies of the nasal mucosa following provocation, eosinophils 
are the predominant cell (25,90). Eosinophils are still present at 24 
hours after provocation, even in the absence of clinical symptoms (25). 
Following several days of provocation, Connell noted eosinophils, a dense 
infiltrate of large foamy cells, and destruction of the basement membrane 
(90). The clinical significance of these findings is unclear (91). 
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In subjects with induced ragweed sensitivity, biopsies 6 hours 
post-provocation were normal, despite the presence of rhinorrhea and 
congestion (25). Many mononuclear cells were seen at 24 hours, while 
nasal smears revealed neutrophils and mononuclear cells. These results 
may not be applicable because of the artificially induced nasal sensitiviy. 
Late Responses in the Lower Respiratory Tract 
Nocturnal asthma. Salter (97) was the first to recognize the 
importance of nocturnal asthma. The etiology of this syndrome is not clear. 
Some have attributed it to variations in the levels of adrenal steroids, 
noting a decrease in the urinary excretion of 17-hydroxycorticosteroids 
coincident with an exacerbation of bronchial obstruction (98). However, 
nocturnal cortisol infusions were ineffective in preventing a fall in 
peak expiratory flow rate (99). 
There may be a decrease in sympathetic tone at night, as suggested 
by a fall in urinary catecholamine excretion (100). Some workers (101) 
have found the bronchi to have a lower threshold to provocation at 
approximately 11 P.M. Yet others (102) have related the decrease in flow 
rate to sleep. Changes in the daily bronchial cycle occur within 36 hours 
of modification of the sleep cycle. It seems unlikely that a metabolic 
cycle could change that rapidly. 
A related finding is that positive skin tests are more easily elicited 
in the evening, than at other times of the day (103). 
The late bronchial response. The late bronchial response (LBR), or 
late asthmatic reaction (24), was first noted by Herxheimer (23) in 1952. 
It begins within 4-10 hours after bronchial provocation, and can last 
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from 30-70 hours, longer responses occurring in more severe reactions. 
The peak reduction in flow rate occurs at more than 8 hours, with the mean 
peak at 17 hours post-provocation (24). The late bronchial response (like 
the LNR), tends to produce greater obstruction than the preceding immediate 
response (17,24). 
Some subjects experience a systemic reaction (5,16,24) associated with 
the LBR; consisting of fever, malaise, leukocytosis, and eosinophilia (16). 
However, the systemic reaction may be unrelated to any allergic response, 
but a product of the antigens used; as it has been noted in control 
subjects without accompanying respiratory symptoms (104). 
The LBR occurs frequently, in 3-73% of patients tested (2,6,10,14, 
17), sometimes occurring in the absence of an immediate response (5,7). 
It is more common in more sensitive patients (14); as determined by skin 
testing, or antigen-specific IgE levels. An increased frequency of 
late responses was also noted in patients with frequent asthmatic attacks 
during the preceding year (17). 
Some studies (16,21) have documented recurrent nocturnal asthma 
following a single provocation, in one case (21) lasting up to five 
subsequent nights. Another study (2) has recorded a LBR lasting up to 
one week. 
The LBR can be elicited by many agents. These include house dust 
(3,7,8), ragweed pollen (14), grass pollen (19), Aspergillus fumigatus 
(5,24), Aspergillus niger (15), avian precipitins (5), tolyene di¬ 
isocyanate (21), cantharidine beetle (18), Prosopis juliflora (a 
perennial Indian tree) pollen (20), and piperazine dihydrochloride (9). 
The late response to Aspergillus fumigatus has been extensively 
studied because of its relationship to allergic bronchopulmonary 
' 
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aspergillosis (ABA) (5,24). As described above, there are often 
systemic symptoms associated with the LBR. This is particularly common 
following provocation with A. fumigatus (24). Also, crepitant rales 
are sometimes noted, in addition to the usual obstructive changes (24). 
This seems to indicate an alveolar process, distinct from the bronchial 
pathology which occurs following provocation with most allergens. 
Treatment of the LBR is more difficult than the preceding immediate 
response. Bronchodi1ators are often ineffective (17,24). DSCG seems to 
be useful in provocation studies (5,8,12,20,34), although there are 
conflicting reports (18,105). 
Corticosteriods are quite effective in preventing the LBR. Oral 
prednisone does not prevent the immediate response, but did suppress the 
expected LBR (24). Inhaled beclomethasone (12) or prednisone (8) both 
inhibit the LBR, without effect on the immediate response. In one case 
(18), one week of prior treatment with prednisone suppressed the LBR, 
while treatment with DSCG failed. Beclomethasone seems to be especially 
useful, as there is no evidence of adrenal suppression when used topically 
(by inhalation) (33). 
The mechanism of the LBR is as obscure as that of the LNR. It has 
been suggested (17) that the LBR may be due to mucosal edema of the small 
airways, and viscous secretions. This would result in early expiratory 
airway closure and gas trapping. Overinflation could thus occur without 
changes in the peak expiratory flow, more a measurement of large airway 
resistance. The LNR, characterized mainly by obstruction (28), probably 
also is due to mucosal edema. The relative ineffectiveness of broncho- 
dilators (17,24) also suggests a "nonbronchospastic" mechanism for the LBR. 
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There is some evidence that IgE is involved in the LBR. ABA is 
associated with high serum concentrations of IgE to Aspergillus fumigatus 
(106). The LBR to ragweed is more likely to occur in subjects with a high 
titer of IgE to ragweed antigen E (14). 
The Arthus reaction has frequently been implicated in the pathogenesis 
of the LBR (5,8,24). Unlike the LNR, the LBR is sometimes associated with 
a systemic response, which is thought to be further evidence of the 
Arthus reaction (24). However, complement levels remain unchanged (16), 
and the systemic reaction seems limited to late responses induced by 
Aspergillus or avian precipitins (5,24). In provocation with house dust 
extract, there was no evidence of a systemic (fever, leukocytosis) or 
alveolar (crepitations, radiographic changes) response accompanying the 
LBR, in 36 patients (8,10). 
Possibly, the LBR (and LNR) is due to mediators released at the time 
of the immediate response (10). This would explain the effectiveness of 
DSCG, which prevents mediator release from mast cells and basophils. The 
mediator(s) involved may be long-acting (7), or may be the result of an 
ongoing immune process. It would be useful to determine if DSCG can 
prevent late responses if given at a time after the occurrence of the 
immediate response. 
Changes in the Peripheral Eosinophil Count in Allergic Diseases 
Peripheral eosinophilia is a hallmark of allergic disease (58). The 
exact role of these leukocytes in allergy is less well-defined. Eosinophil 
counts are increased during the attack stage (during an asthmatic attack) 
of bronchial asthma (57). These individuals also had a greater number of 
• 
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vacuolated eosinophils, first noted by Connell (107), signifying 
phagocytosis of antigen-antibody complexes (108). 
Increases in the eosinophil count occur immediately following 
bronchial provocation (24,109). However, the eosinophilia does not 
correlate with the occurrence of an immediate bronchial response (109). 
The maximum increase in eosinophil counts occurs at 6 hours after 
provocation (24) and remains elevated until at least 24 hours after 
provocation. This was accompanied by leukocytosis, and a late systemic 
reaction (see previous section). 
Peripheral eosinophil counts are not useful in the diagnosis of 
allergic rhinitis (59), especially compared to examination of the nasal 
smear. 
Changes in the Peripheral Basophil Count in Allergic Diseases 
The study of basophils in allergy is a recent phenomenon, probably 
spurred by the guinea pig model of CBH (50-52) (see next section). There 
is a significant increase in the basophil count in ragweed-sensitive hay 
fever sufferers during ragweed season (56). It is also interesting that 
nonatopic subjects have a significant, but much smaller, elevation of 
basophils during this time. This may be due to a nonspecific physiologic 
response to foreign antigens, occurring in normal individuals (56); or it 
may be related to other environmental factors (changes in temperature, 
humidity, etc.). 
Other studies (54,57) have demonstrated an increase in peripheral 
basophils prior (within 18 hours) to an asthmatic attack, in the "pre- 
3 
attack stage". Basophil counts greater than 65/mm were always associated 
with an asthmatic attack (54). 
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Basophils have been found in the sputa of patients during an 
asthmatic attack (110), which were absent during remission periods. 
Provocation studies (55), with intravenous injection of allergen, have 
demonstrated a decrease in peripheral basophils, associated with 
degranulation. These studies seem to indicate a migration of basophils 
to affected target organs, followed by degranulation and release of 
mediators. 
Cutaneous Basophil Hypersensitivity 
Cutaneous basophil hypersensitivity (CBH) is an important animal 
model of non-immediate hypersensitivity reactions (111,112). Dvorak (52) 
described the CBH reaction as circumscribed erythematous non-indurated 
macules. These first appear at 6 hours, peak at 24 hours, and are 
significantly decreased by 48 hours. 
Jones and Mote (63) produced a similar lesion by inoculating humans 
with rabbit serum. Raffel and Newel (113) coined the term "Jones-Mote 
reaction" to distinguish these skin reactions, produced transiently after 
immunization alone or with incomplete Freund's adjuvant, from delayed-type 
hypersensitivity (DTH) reactions. CBH wanes at the time circulating 
antibody appears, whereas DTH persists, increasing with time. 
Antigens which produce only DTH cannot produce CBH; and those that 
only stimulate antibody formation do result in a CBH response (51). 
Carageenan has no effect on CBH, but markedly decreases the tuberculin 
reaction, an example of DTH (51). High doses of intravenous ovalbumin, 
yielding tolerance for DTH, are capable of producing CBH and subsequent 
formation of IgGl (in guinea pigs) (114). This antibody is homocytotropic, 
similar to IgE in man (115). 
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Early studies demonstrated that CBH (116) and Jones-Mote reactions 
(117) could be passively transferred with cells from draining lymph nodes, 
but not with serum. However, Askenase (118) demonstrated that the transfer 
of CBH with immune sera was possible, although the specific factor was 
still obscure. 
T cells can initiate CBH (119), and anti-T cell (120) or anti¬ 
lymphocyte (51) serum inhibits CBH. B cells can also initiate CBH (119), 
confusing this picture even more. 
Since CBH reactions occur transiently during a period of little or 
no specific antibody (51), it was considered that antibody might inhibit 
CBH. Following immunization with doses of antigens -- dinitrochlorobenzene 
(116) or vaccinia virus (121)--insufficient to produce an antibody 
response, the CBH reaction can be elicited indefinitely. Large doses of 
passive antiserum do not prevent induction of CBH, but only partially 
inhibit its expression (122). This effect is nonspecific, and is probably 
a result of vascular damage by antigen-antibody complexes. 
Microscopic examination of CBH reactions reveals a mixed infiltrate, 
dominated by mononuclear cells and basophils (52,122). 32-44% of the 
cells were basophils, and mononuclear cells comprised 55-65% of the 
infiltrate. Scattered neutrophils (3%) and eosinophils (2%) were also 
seen. 
Basophils were often noted in close association with macrophages (52). 
In fact, many sections seem to demonstrate a phagocytosis of basophils 
by the macrophages. The explanation for this is unclear. 
Unlike the LCR (49), there is no evidence of fibrin deposition in 
CBH reactions (123). Fibrin accumulation is prominent in DTH reactions. 
and is probably responsible for the associated induration. 
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It has recently been demonstrated (124) that basophils are not 
restricted to CBH reactions. Basophils were found in more than 50% of 
strongly-positive tuberculin reactions (DTH). This basophilic infiltrate 
can also be found in human tuberculin reactions (112). 
There are several non-immediate immune responses in guinea pigs. 
CBH is described above. Colvin et al. (122) also describe the "late 
reaction". These reactions are elicited at 4-6 weeks after immunization, 
producing a tensely edematous lesion, peaking at 15-30 minutes. Within 
4-6 hours the edema diminishes, becoming a moderately hemorrhagic lesion. 
By 24 hours, only a slightly raised, pale red area remains; which 
totally disappears by 96 hours. 
Evaluation of this reaction suggests that there are three sequential 
but overlapping phases (122). The first, cutaneous anaphylaxis, is 
similar to the wheal and flare. The second component is an Arthus 
reaction, with venous thrombosis, erythrocyte extravasation, and a 
granulocytic infiltrate. The third phase is a weak CBH reaction. 
It is significant that a chronological link is found between the 
Arthus reaction and CBH. Many observers have attributed late allergic 
reactions to Type III hypersensitivity, yet others have found no evidence 
of immune complex disease (see previous sections). CBH has also been 
suggested as a cause of late allergic reactions, but has had little 
experimental support. The "late reaction" may be more relevant to 
clinical allergy than pure CBH, as it does not seem to be a transient 
response. 
Basophils involved in "late reactions" are different from those in 
CBH (125). Basophils from CBH infiltrates could not form rosettes with 
antigens, but one-third of basophils in "late reactions" were rosette- 
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formers. This may reflect an immunological difference between these 
two groups of basophils. 
Early studies (52,116) demonstrated no evidence of basophilic 
histamine release. However, Askenase et al. (126) recently described 
cutaneous basophil anaphylaxis, resulting from tertiary challenge of 
CBH reactions. Vasoactive amines were released from basophils, and 
the number of basophils decreased 50% within 20 minutes of challenge. 
This evidence confirms a functional role for basophils in CBH reactions -- 
a depot for further immunological attack, directed to the "battlefield" 
by the lymphocyte. 
In addition to mediating local immune responses, basophils have 
been involved in systemic immunity, systemic cutaneous basophil hyper¬ 
sensitivity (127). This response can best be elicited at 5-7 days after 
sensitization with soluble proteins or sheep erythrocytes. The response 
consists of a generalized maculopapular rash, maximal at 18-24 hours 
after challenge. Microscopically, the rash resembles CBH reactions. 
The rash is accompanied by eosinophi1ia, and subsequently basophilia at 
48 hours. The significance of this response is not clear. 
It is obvious that there is much confusion concerning the clinical 
significance and mediation of late allergic responses. This study 
documents further attempts to elicit late cutaneous and nasal responses, 
with special emphasis on the role of eosinophils and basophils -- 
analyzing both blood and nasal samples. 
r 
MATERIALS AND METHODS 
Overall Design 
Volunteers with allergic rhinitis participated in preliminary testing, 
for the purpose of selecting those individuals most likely to produce a 
LNR, via NPT. Preliminary testing consisted of: 1) standardized low-dose 
battery of intradermal skin tests; 2) repeat high-dose testing. All 
subjects participated in the former, to select subjects with a marked 
immediate cutaneous response. Some subjects also participated in the 
latter, to select subjects with a LCR; more likely following higher doses 
of antigen (14,46). Late allergic responses are more likely in highly 
sensitive individuals (14), and elicitation of the LNR has been correlated 
with the LCR (24,26). 
Preliminary Skin Testing 
Volunteer subjects with allergic rhinitis were recruited during the 
period October 1979 to January 1980. All subjects signed and received a 
copy of a consent form approved by the Human Investigation Committee of 
Yale University School of Medicine and Yale-New Haven Hospital. The 
individuals skin tested ranged in age from 22 to 55. Previous immuno¬ 
therapy was not a determinant for subject eligibility, but individuals 
on chronic antihistamine, DSCG, or steroid therapy were excluded. 
All individuals received a standardized battery of 11 intradermal 
skin tests. No antihistamines were taken in the 24 hours preceding 
testing. The allergen extract was injected through a #27 gauge needle 
on the posterior surface of the upper arm (5-6 tests on each arm). A 




was used for each test (approximately .02 ml). The skin tests were read 
at 15 minutes after injection. 
Allergens. All allergens were made from stock solutions of 10,000 
or 20,000 protein nitrogen units (PNU)/ml , obtained from Center Laboratories. 
Dilutions were made serially in sterile 0.4% phenol-0.9% saline. (This 
investigator used standard solutions for the Allergy Clinic of Yale-New 
Haven Hospital.) 
The following allergen extracts were used: 
1) dust 1000 PNU/ml (house dust) 
2) dog 100 PNU/ml (dog epithelium) 
3) cat 100 PNU/ml (cat epithelium) 
4) grass 100 PNU/ml (mixed grasses--made from timothy, orchard, 
June, red top, and sweet vernal pollens) 
5) ragweed 100 PNU/ml (mixed ragweed--made from tall and short 
ragweed pollens) 
6) plantain 100 PNU/ml (English plantain pollen) 
7) Alternaria 100 PNU/ml (a mold) 
8) horse 100 PNU/ml (horse epithelium) 
9) feathers 100 PNU/ml (mixed feathers--chicken, duck and goose) 
10) trees 100 PNU/ml (mixed trees--ash, beech, birch, elm, hickory, 
maple, oak, and poplar pollens) 
11) Hormodendrum 100 PNU/ml (a mold) 




0 no visible or palpable wheal 
1+ wheal less than 10 mm in diameter, surrounded by erythema 
2+ wheal 10-15 mm in diameter with erythema 
3+ wheal greater than 15 mm in diameter with erythema 
4+ wheal greater than 15 mm in diameter with erythema, and with 
pseudopods 
Repeat (High-Dose) Skin Testing 
Subjects received 2-3 intradermal skin tests. All allergens used 
elicited a 2+ or greater response in preliminary testing. Dose was 
usually 10-fold greater than in preliminary test, although the low dose 
was repeated for some subjects. One test was placed on each arm, using 
the method described above. (In addition, one subject received a third 
test on the volar surface of the forearm.) 
Skin tests were read at 15 minutes, 6 hours, and 24 hours after 
inoculation. The diameter, in two perpendicular directions, of the lesion 
(wheal at 15 minutes, induration at 6 hours and 24 hours) was recorded. 
Nasal Provocation Testing 
Selection of subjects. Subjects were selected on the basis of 
preliminary test results. Criteria for selection were as follows: 
1) No significant history of bronchospasm. 2) A result of 3+ or 4+ on 
preliminary testing to an allergen, with a corroborative clinical history. 
3) No significant sensitivity (0 or 1+) to allergens encountered during a 
routine day (i.e. pets, dust, occupational exposure). 4) No current 
rhinitic symptoms off all anti-allergy medications. 
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Nasal provocation. All nasal provocation was performed during the 
period December 1979 to January 1980. Testing was begun between 8 A.M. 
and 10 A.M. Prior to testing, blood and nasal samples were obtained, and 
baseline nasal resistance was determined. 
A total of 0.4 ml (82) of allergen (10,000-20,000 PNU/ml) was 
alternately sprayed into both nostrils, with forced sniffing. A plastic 
atomizer bottle, capable of delivering its entire volume, was used for 
this purpose. 
Nasal sections were collected at 10-15 minutes after provocation. 
Blood samples and nasal resistance measurements were also obtained at 15 
minutes after provocation. 
Blood and nasal samples, and nasal resistance measurements were 
repeated at 7 hours and 24 hours after provocation. 
Nasal secretions. Subjects were asked to blow (or sneeze) into small 
plastic (Glad) bags. A small sample from each bag was smeared onto glass 
slides using a wooden applicator. 
Blood samples. Whole blood was collected in purple Vacutainer 
(Becton-Dickinson) tubes (0.1 ml EDTA additive). Additional samples 
(serum) were obtained for future analysis. 
Rhinomanometry. The measurement of nasal resistance utilized the 
technique of rhinomanometry (RM). Measurements were made on a Cottle 
Nasal Pressure/Flow Recorder -- Model PF-102 (Instrumentation and Control 




Rhinomanometer (Cottle Nasal Pressure/Flow Recorder) 
Note flow meter in upper left corner. 
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An anterior rhinomanometric method (74) was used for this study. 
Two tubes were connected to the subject's nose, one in each nostril (see 
Figure 2). Air flowed through one tube, during inspiration, while the 
other tube was connected to the pressure transducer. Separate measure¬ 
ments of each nostril, reversing tubes, were obtained at several flow 
rates (1-6 L/min). The subject was asked to maintain a constant flow, 
utilizing the flow meter mounted on the apparatus (see Figure 1). 
Simultaneous pressure recordings were obtained on the strip recorder 
(see Figure 3). 
Nasal resistance was calculated by dividing the recorded pressure 
by the known flow — using an assumption of linearity at low flow rates 
(29,77,78) -- and averaging the resistance at several flow rates (see 
Figure 3). 
Total nasal resistance. The total resistance (Rt) of the nose is 
equivalent to the sum of the two parallel "resistors", the right (Rr) 
and left (Rl) nostrils. Therefore, 1/Rt = 1/Rr + 1/R1 (75), or 
Rt = (Rr X Rl)/(Rr + Rl). 
Nasal ratio. The nasal ratio (NR) is defined as the ratio of the 
resistance of the "more obstructed" to the "less obstructed" nostril. 
The definition of "more obstructed" is determined at the first post¬ 
provocation measurement (15 minutes), and does not change with future 










Pressure tracing for one subject (MZ) (left nostril, 24 hours post¬ 
provocation) at several flow rates. 
The subject was first instructed to maintain a nasal flow of 2L/min 
(top tracing, left). The recorded pressure was 2.8, with a calculated 
resistance of 1.4. The calculated resistances at 3, 4 and 5 L/min were 




Stains. Slides were irrmediately fixed in ethanol for at least 30 
minutes before staining with Giemsa or toluidine blue. Giemsa stain 
(original azure blend type, Harleco), 7.415 g/1 in methanol, was diluted 
1:20 in distilled water immediately prior to use. 1% toluidine blue 
was obtained from the Clinical Hematology Laboratory, Yale-New Haven 
Hospital, and diluted 1:20 in ethanol before use. 
Slides were stained in Giemsa for 15-30 minutes, and then rinsed 
gently in tap water. 
For comparison, identical slides were stained for 5 minutes in 0.05% 
toluidine blue, and then rinsed by 5 dips in ethanol, and air dried (53). 
Nasal cytology. Each slide was assessed semi-quantitatively for 
total cells, epithelial cells, neutrophils, lymphocytes, eosinophils, 
and basophils. The method used is as follows: 
0 no cells seen on entire slide 
1+ at least one cell seen 
2+ two or more cells in same low-power field (LPF) (100X) 
3+ three or more cells in same LPF, and two or more cells in 
same high-power field (HPF) (970X), within that LPF 
4+ two or more HPFs containing two or more cells, within one LPF 
5+ two or more 4+ LPFs on same slide 
In addition, the amount of debris was defined as the total 




Total white blood cell count (WBC). The tube was gently mixed 
immediately prior to dilution, to prevent separation of cells and plasma. 
0.025 ml of blood was diluted in .475 ml 3% glacial acetic acid, using a 
Unopette test 5856 (Becton-Dickinson). The mixture was gently shaken 
to ensure proper mixing, and allowed to sit at room temperature for 10-30 
minutes, ample time for erythrocyte hemolysis. 0.009 ml of blood-acetic 
acid solution was added to each chamber of an Improved Neubauer hemo- 
3 
cytometer. Both chambers (0.1 mm each) were counted, and the total 
3 
number of leukocytes multiplied by 100 (20-fold dilution, 0.2 mm counted). 
If there was a significant difference between the chambers, a repeat count 
was made. 
Pifferential. A drop of blood was placed on a glass slide, gently 
smeared using a cover slip, and allowed to dry. Slides were stained 
with Wright's stain (obtained from Clinical Hematology Laboratory) for 
3 minutes, followed by the addition of Wright's buffer (obtained from 
same source) for 7 minutes. Slides were then rinsed in tap water and 
allowed to air dry. 
100 leukocytes were counted under high power (970X). Segmented 
neutrophil (seg), band neutrophil (band), lymphocyte, monocyte, 
eosinophil and basophil counts were determined by multiplying the 
percentage of each by the WBC. 
Statistical Methods 
Nonparametric methods were used for all analyses of significance (128); 
including the Wilcoxon signed rank test, the Wilcoxon rank sum test, and 
Spearman's rank correlation. 

RESULTS 
Preliminary Skin Testing 
23 individuals participated in preliminary skin testing. 16/23 
(70%) were highly sensitive (3+ or 4+) to at least one of the allergens 
used. The sensitivity profile of the atopic subjects is shown in Table 
III. Dust, grass, and ragweed were the most common sensitivities in 
this group. 
Elicitation of LCR 
6 subjects received high-dose skin testing (total of 13 tests) in 
order to assess the frequency of the LCR. The results are seen in Table 
IV. A significant LCR persisting at least 24 hours could be elicited 
in all subjects, to at least one allergen. 
One subject (JGa) had taken an antihistamine several hours prior 
to testing. There was a marked decrease in the immediate response 
(compared to previous testing), but it was followed by a significant LCR. 
There was a general trend towards larger LCRs following larger 
immediate responses; but the correlation was not statistically 
significant. 
Nasal Provocation Testing 
Immediate nasal response. All 11 subjects had at least a mild 
clinical response (see Table V), with most (9/11) demonstrating significant 






Allergic Profile of Subjects 
A11erqens 
Subject 1 2 3 4 5 6 7 8 9 10 11 
A. Subject of nasal provocation testing 
DB 0 0 0 4+ 3+ 0 0 0 0 0 0 
MZ 3+ 0 0 0 0 0 0 0 0 0 0 
JGi 3+ 3+ 2+ 3+ 3+ 0 1+ 1+ 0 0 1+ 
JGa 3+ 3+ 0 3+ 1+ 0 1+ 0 0 0 0 
RD 0 1+ 0 4+ 0 0 0 0 0 0 0 
SD 1+ 3+ 1+ 4+ 1+ 0 1+ 0 0 0 1+ 
RZ 3+ 0 2+ 2+ 4+ 1+ 0 1+ 0 0 0 
LS 3+ 1+ 0 0 3+ 1+ 1+ 0 0 1+ 0 
BM 3+ 3+ 3+ 4+ 1+ 4+ 2+ 1 0 0 0 
JN 3+ 0 3+ 0 3+ 0 3+ 0 0 0 0 
PG 1+ 0 0 4+ 4+ 2+ 1+ 0 0 4+ 0 
B. Other highly sensitive subjects 
(at least one 3+ or 4+ response) 
DO 2+ 1+ 4+ 3+ 0 4+ 0 1+ 0 4+ 0 
GC 0 0 3+ 0 0 0 0 0 0 0 0 
MR 2+ 0 0 0 3+ 0 3+ 0 0 0 3+ 
AE 3+ 2+ 4+ 0 1+ 1+ 0 2+ 1+ 1+ 2+ 
RL 3+ 3+ 2+ 4+ 0 0 0 4+ 1+ 0 0 
C. % of subjects with given sensitivity 
Sensitivity 
3+ or 56% 31% 31% 56% 44% 12% 12% 6% 0% 12% 6% 
greater 
2+ or 69% 38% 50% 62% 44% 19% 19% 12% 0% 12% 12% 
greater 
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Nasal Provocation Testing 
Subject Rr R1 Rt NR Clinical Response 
DB A 1.3 1.1 0.6 0.8 
B 1.5 2.0 0.9 1.3 marked sneezing, obstruction 
C 1.3 1.2 0.6 0.9 none 
D 1.5 1.2 0.7 0.8 none 
MZ A 1.0 1.1 0.5 0.9 
B 1.5 1.0 0.6 1.5 mild coryza, obstruction 
C 1.0 1.0 0.5 1.0 none 
D 0.8 1.3 0.5 0.6 none 
JGi A 2.0 1.0 0.7 2.0 
B + - + + marked sneezing, obstruction 
C 6.0 0.3 0.3 20.0 none 
D 5.9 0.6 0.5 9.8 none 
JGa A 1.2 1.1 0.6 0.9 
B 1.2 1.5 0.7 1.1 marked sneezing 
C 1.3 1.4 0.7 1.1 "packed sinuses" 
D 1.2 1.3 0.6 1.1 "congested in back" 
RD A 1.2 1.3 0.6 0.9 
B 2.6 1.7 1.0 1.5 marked sneezing, obstruction 
C 1.2 1.2 0.6 1.0 none 
D 1.1 1.3 0.6 0.8 none 
SD A 1.2 1.2 0.6 1.0 
B + - + + marked sneezing, obstruction 
C 1.1 1.3 0.6 0.8 headache 
D 1.2 1.3 0.6 0.9 none 
RZ A 1 .4 1.4 0.7 1.0 
B 1.3 1.4 0.7 1.1 mild coryza 
C 1.2 1.3 0.6 1.1 none 
D 1.1 1.1 0.6 1.0 none 
LS A 1.1 1.3 0.6 1.2 
B - + + + marked sneezing, obstruction 
C 1.0 1.9 0.7 1.9 none 
D 1.6 0.9 0.6 0.6 none 
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TABLE V (continued) 
Nasal Provocation Testing 
Subject Rr Rl_ Rt NR Clinical Response 
BM A 1.2 1.1 0.6 1.1 
B 6.4 0.4 0.4 16.0 marked sneezing, obstruction 
angioedema of uvula and palate 
C 1 .2 1.2 0.6 1.0 moderate angioedema 
D 1.2 1.1 0.6 1.1 none 
JN A 1.1 1.2 0.6 0.9 
B 2.0 1.2 0.8 1.6 moderate sneezing, obstruction 
C 1.5 1 .2 0.7 1.2 none 
D 1.1 1.1 0.6 1.0 sore throat 
PG A 5.7 1.0 0.9 0.2 "not congested" 
B 1.1 6.1 0.9 5.5 marked sneezing, obstruction 
C 4.9 0.8 0.7 0.2 none 
D 3.2 1.2 0.9 0.4 none 
A pre -provocation + unmeasurably high 
B 15 min. post- -provocation - unmeasurably low 
C 6 hr. post-provocation 
24 hr. post-provocation D 
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The rhinomanometric data was somewhat confusing. Three subjects 
(JGi,SD,LS) were virtually totally obstructed at 15 minutes, as the nasal 
resistance was unmeasurably high on one side. Simultaneously, the 
resistance on the other side was close to zero, as determined by RM. 
Total resistance in this case was judged "+" (infinitely high, for 
statistical purposes). 
One subject (BM) had a marked increase in Rr, with a concomittant 
decrease in R1. However, the calculated Rt was less than pre-provocation 
Overall, there was not a statistically significant correlation 
between the clinical response, and post-provocation increases in Rt or NR 
Late nasal response. No subjects complained of obstruction at 7 
hours or 24 hours post-provocation. Two subjects (DB,BM) reported some 
mild obstruction in the evening following provocation. One subject (SD) 
complained of a headache at 7 hours post-provocation, and another (JGa) 
noted some sinus congestion at 7 hours and 24 hours. In addition, one 
subject (JN) had a sore throat at 24 hours, of doubtful relation to NPT. 
7/11 subjects had no increase in Rt at 7 hours or 24 hours post¬ 
provocation (compared to pre-provocation), and the increase was only 0.1 
in the other 4 subjects. Only two subjects (JGi,LS) had greater than a 
50% increase in NR at 7 hours. JGi had a 900% increase in NR at 7 hours, 
and a 390% increase at 24 hours. Neither of these subjects noted any 
clinical symptoms after cessation of the immediate response. 
Comp!ication. An unforeseen, and previously unreported complication 
of NPT was noted in one subject (BM). Severe pharyngeal irritation was 
noted within 5 minutes after provocation, which progressed to localized 
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angioedema of the uvula and soft palate within 15 minutes (see Figure 4). 
There was no dyspnea, or wheezes on physical exam, but phonation was 
markedly impaired. The subject was offered epinephrine, but refused, 
preferring to continue with the study. The edema subsided gradually over 
the next 24 hours. 
Leukocyte Counts (Table VI) 
The mean WBC and differential counts were within normal limits in 
each of the four analysis groups (129). 
WBC. There was no overall increase in the WBC in the first 15 
minutes, as seen in Table VI. However, there was a significant (p<.05) 
correlation between the increase in NR (at 15 minutes) with changes in 
WBC over the same period (see Table VII). 
There was significant (p<.05) increase in the WBC at 7 hours vs. 
pre-provocation, and vs. 15 minutes; including a significant (p<.05) 
increase in segmented neutrophils and monocytes (vs. 15 minutes). Other 
cell counts (bands, lymphocytes) were also increased, but not significantly 
(P>.05). 
Eosinophils (Table VIII). The percentage of eosinophils fell over 
the first 7 hours post-provocation (p<.05) from 2.1 + 1.9% (mean + S.D.) 
to 0.9 + 1.1%. The absolute number of eosinophils also decreased, but 
not significantly (p>.05). 
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Changes in Eosinophils during NPT 
Eosinophi1s 
Time Total 1o 
Pre-prov. 125 + 131 2.1 + 1.9 
15 min. 60 + 81 1.2 + 1.3 
7 hr. 78+114 0.9 + 1.1 
24 hr. 155 + 147 2.4 + 2.1 




Giemsa. There was no obvious overall difference between the pre¬ 
provocation and post-provocation smears. The epithelial cell was most 
frequently seen (Table IX), followed by neutrophils, with occasional lym¬ 
phocytes. Eosinophils were only seen in one smear (RZ at 7 hours), and 
no basophils were visible in this preparation. 
There was a significant (p<.05) difference (using chi-square) in the 
frequency of neutrophils among the following two groups of slides: those 
with 1) many epithelial cells; and 2) none or few epithelial cells (see 
Table X). The converse was also true (i.e. relating frequency of epithelial 
cells to frequency of neutrophils). 
There was no difference in the frequency of lymphocytes in either 
set of groups noted above (see Table X). 
More succinctly, neutrophils occurred more frequently in the presence 
of epithelial cells, but lymphocytes appeared independently of both. 
Examination of the smears was made difficult by the high frequency 
of dead, poorly-staining cells, which were commonly fragmented, and 
difficult to identify. These cells were counted in "total cells", but not 
individually classified. 
Toluidine blue. Very few cells were seen using this staining method, 





% of slides with given frequency of cells (n=44) 
Cell None Few Many 
Total 4.5% 34.1% 61.4% 
cel 1 s 
Epithelial 15.9% 38.6% 45.5% 
cel 1 s 
Neutrophil 65.9% 15.9% 18.2% 
Lymphocyte 86.4% 11.4% 2.3% 
Eosinophi1 97.7% 2.3% -- 




Interrelationship Between the Frequency of Occurrence 
of Epithelial Cells, Neutrophils and Lymphocytes 
# of slides with given frequency of specific cell 
★ 
Neutrophi1 Lymphocyte 
Slides with None Few Many None Few Many 
(0) (1+-3+) (4+,5+) 
Many 
epithelia 1 
cel 1 s 
9 4 7 17 2 1 
None or few 
epithelia1 
cel 1 s 




None Few Many None Few Many 
Many 
neutrophi1s 
0 1 7 6 1 1 
None or few 
neutrophils 
7 16 3 32 4 0 
★ 
significant (p<.05) difference between two groups 

DISCUSSION 
The Occurrence of the Late Nasal Response 
The primary goal of this investigation was to reproducibly elicit 
the LNR. Some investigators (24,26,29) have noted such a response as a 
common succession to NPT. Others (28) have relied on a small subset of 
their subject population for studies on the LNR. Richerson et al. (38) 
were not able to objectively document the LNR in any of 21 patients 
tested. The results of this study are in agreement with Richerson's; as 
there was no definite objective LNR in the 11 subjects examined. 
Difficulty of elicitation. It is unclear whether the problem is in 
elicitation of the LNR, or in diagnosis of such a response. Schumacher 
et al. (29) were only able to elicit the LNR when nasal threshold doses 
were exceeded. However, these doses frequently induced severe symptoms 
of persistent sneezing, palatal and pharyngeal itching, conjunctivitis 
and headache; and dyspnea was noted in one patient requiring broncho- 
dilators. There is also a danger of systemic anaphylaxis, as a significant 
quantity of allergen is absorbed through the nasal mucous membrane (87). 
A severe reaction was induced in one subject (BM) in this study, 
angioedema of the uvula and soft palate; affecting phonation, but not 
respiration. It is not clear whether this was due to the dose of allergen 
(4000 PNU), or an uneven deposition of allergen to the affected areas. 
Elicitation of the LNR may require a more gradual administration of 
the allergen, as profuse sneezing will expel most of the contents of the 
nasal lumen. Slavin et al. (25) used nasal packs for provocation, which 




Another possibility is a requirement for priming, prior to the admin¬ 
istration of allergen. Connell's studies (88-91) on the "priming effect" 
note anatomical changes in the nasal mucosa after repeated challenge. It 
is possible that similar changes are necessary for the elicitation of the 
LNR. Some individuals might have permanent changes, and would comprise a 
small subset which could readily produce a LNR. 
Difficulty of observation. The LNR may be a common response, but 
difficult to diagnose by some techniques. In those patients with a marked 
response, diagnosis would be obvious. But some subjects, as in this 
study, complain of mild obstruction or other late symptoms, such as sinus 
congestion or headache. Rhinomanometry failed to confirm a LNR in this 
study. 
Clinical late responses may be due to posterior obstruction, which 
may not significantly change nasal resistance. This is analogous to the 
proposed mechanism of mucosal edema of the small airways, in the LBR (17), 
which may not decrease peak expiratory flow. 
Total nasal resistance (Rt) was not a reliable indicator of nasal 
obstruction, as one subject's (BM) Rt decreased following NPT, simultaneous 
with a marked clinical response. This was probably due to artifactually 
low resistance readings in the less obstructed nostril, possibly a result 
of poor pressure transmission through the more obstructed side. In addition, 
uneven deposition of allergen could have resulted in congestion of one 
nostril, with reciprocal decongestion of the opposite nostril (130), causing 
uncertain effects on Rt. 
Rapid changes in the NR may be useful as a guide to an immediate 
response, but changes occurring over several hours may simply be a manifestation 
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of a normal physiologic nasal cycle (75,1 31 ,1 32). Heetderks (131) first 
demonstrated the existence of a nasal cycle, occurring over lengths of 
time ranging from 30 minutes to 4 hours. Hasegawa and Kern (75) found at 
least one complete cycle in 72% of normal subjects, with a mean duration 
of 2.6 hours. Cycles varied from 1 to 6 hours, longest in older subjects. 
If there is deviation of the nasal septum, there will be a high 
baseline NR. This could also obscure the existence of a LNR, a possibility 
in one subject (PG) in this study. 
In addition, it is difficult to control for the effects of position 
or temperature changes (133), and directed light or air flow (134). 
It may be best to rely on clinical diagnosis. Malmberg et al. (135) 
found RM less sensitive than clinical criteria in detecting a positive 
nasal response. The results of this study also suggest that RM is not 
a reliable method of assessing nasal reaction, although diagnosis could 
probably be markedly improved with more elaborate equipment. 
Changes in Leukocytes Following Nasal Provocation 
Leukocytosis is sometimes seen in late bronchial responses (5,16,24). 
Therefore, it was considered that changes in leukocytes might occur in 
association with the late nasal response. However, as noted above, there 
was no clear documentation of the occurrence of the LNR in this study. 
Changes in WBC. The WBC increased over the 7 hours following 
provocation, from mid-morning to late afternoon. It is unlikely that 
this is due to an immune response, as the WBC normally is higher in the 
afternoon, peaking at around midnight (136,137). The diurnal rhythm is 
probably a result of changes in corticosteroid levels (138). In addition, 
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changes in light, exercise, or stress can all affect the WBC (137). As 
this study did not use a non-provoked control group, no conclusions can 
be drawn concerning the effect of NPT upon the WBC. 
Also noted was a correlation between WBC changes, and increases in the 
NR, at 15 minutes post-provocation. This is most likely related to the 
stress of provocation, greater in those with a more severe immediate 
response. 
Changes in segmented neutrophils and monocytes. Changes in neutrophil 
counts tend to be parallel to those of the WBC (137). The increase in 
monocytes at 7 hours (vs. 15 minutes) was unexpected, and its etiology is 
not clear. 
Changes in eosinophils. The normal eosinophil count decreases during 
the morning hours, with a nadir around noon (136,137,139-144). The 
eosinophil count rises during the early afternoon, peaking around midnight. 
Late afternoon counts are usually slightly higher than morning values. 
In this study, there was an insignificant decrease in eosinophils 
following provocation, but a significant decrease in the percentage of 
eosinophils. This result is interesting, as one would expect a control 
group to have slightly higher eosinophil counts at 7 hours post-provocation 
(late afternoon). In addition, following bronchial provocation, eosinophil 
counts increased at 6 hours (24); although this was followed at 24 hours 
by a late response. 
Unfortunately, absolute eosinophil counts were not done, and further 
studies are required before concluding the existence of eosinophil changes 
following nasal provocation. 
* 
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Occurrence of the Late Cutaneous Response 
The frequency of the LCR was 100% in the 6 subjects tested. This 
required high doses of allergen (approximately 200 PNU). Robertson et 
al. (14) have demonstrated similar results. As also described in prior 
studies (38), larger immediate responses tended to yield larger LCRs. 
Changes in Nasal Cytology Following Nasal Provocation 
It was considered that changes in the eosinophil or basophil population 
of the nasal mucosa might occur at the time of the LNR. However, there 
was no obvious change in any component of the nasal smear, at any time 
following NPT. 
Eosinophils were a rare entity, probably requiring more than one 
provocation to be noted in the nasal smear. 
Basophils have previously been found in the nasal secretions of 
patients with allergic rhinitis, but only when symptomatic (53). Again, 
one provocation is probably not a significant enough challenge to 
adequately induce a model of allergic rhinitis. 
It is possible that basophils and/or eosinophils were present, but 
destroyed in the preparation of the slides. Further refinement of this 
technique may yield more conclusive results regarding the population of 
the provoked nasal mucosa. 
The liberation of neutrophils and epithelial cells into nasal 
secretions may have a common basis, as the occurrence of many epithelial 
cells was often associated with a high frequency of neutrophils. However, 
lymphocytes occurred independently, suggesting that there is little 
interaction between lymphocytes, and neutrophils and/or epithelial cells. 

SUMMARY 
1) The LNR is difficult to elicit and/or document. 
2) In contrast, the LCR can be elicited in virtually all atopic 
subjects, using suprathreshold intradermal doses. 
3) Nasal provocation testing may be useful clinically as a test for 
sensitivity, but a single provocation does not yield a complete experimental 
model for allergic rhinitis. 
4) Attempts to induce late allergic responses using high doses of 
allergen may be extremely dangerous. 
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